extens
glycosyl
envelop
spike
human
simian
immunodefici
viru
hiv
siv
import
factor
resist
virus
neutral
antibodi
three
close
space
site
nlink
carbohydr
attach
rhesu
macaqu
experiment
infect
mutant
version
lack
two
three
carbohydr
site
develop
strong
serum
reactiv
mutat
peptid
sequenc
site
glycosyl
well
high
titer
neutral
activ
mutant
virus
e
yust
et
al
j
virol
howev
whether
antibodi
recogn
underli
peptid
neutral
activ
directli
demonstr
describ
isol
character
three
monoclon
antibodi
one
mutantinfect
monkey
three
antibodi
react
mutant
viral
particl
also
peptid
correspond
mutat
sequenc
slight
differ
peptid
specif
observ
among
three
antibodi
sequenc
analysi
reveal
heavi
chain
three
antibodi
deriv
germ
line
heavychain
segment
differ
sequenc
complementaritydetermin
region
light
chain
three
antibodi
close
relat
one
anoth
three
antibodi
neutral
activ
mutant
virus
defici
carbohydr
attach
neutral
parent
result
demonstr
unambigu
antibodi
specif
peptid
sequenc
underli
carbohydr
effect
neutral
siv
carbohydr
absent
howev
presenc
carbohydr
effect
shield
viru
antibodi
would
otherwis
neutral
viral
infect
vaccin
base
elicit
cellular
immun
respons
correl
antibodi
respons
weakli
protect
effect
thai
trial
refocus
effort
elicit
antibodi
respons
hiv
type
infect
individu
make
antibodi
unusu
broad
potent
neutral
activ
howev
abil
elicit
antibodi
immunogen
far
remain
elus
certainli
one
problem
enorm
sequenc
variabl
envelop
glycoprotein
anoth
extent
envelop
glycoprotein
shield
carbohydr
carbohydr
constitut
mass
surfac
subunit
fact
survey
perform
myer
lenroot
approxim
protein
sequenc
least
one
potenti
nlink
glycosyl
site
swissprot
librari
show
number
glycosyl
site
rank
top
extent
kind
modif
carbohydr
limit
immunogen
antigen
envelop
glycoprotein
evid
suggest
everevolv
glycan
shield
serv
protect
conserv
region
molecul
might
otherwis
target
antibodi
could
neutral
viral
infect
commonli
use
clone
viru
defin
sequenc
infecti
pathogen
rhesu
monkey
site
nlink
carbohydr
attach
asnxserthr
three
close
space
site
locat
number
site
gener
highli
conserv
simian
immunodefici
viru
siv
although
carbohydr
rigor
shown
shield
epitop
would
otherwis
target
neutral
antibodi
nab
correspond
inform
carbohydr
spars
sera
monkey
consist
fail
show
reactiv
peptid
sequenc
underli
site
carbohydr
attach
moreov
accord
lo
alamo
molecular
immunolog
databas
larg
number
antibodi
recogn
sequenc
flank
area
glycosyl
attach
one
antibodi
mous
origin
whose
epitop
map
underli
sequenc
line
yust
et
al
shown
rhesu
macaqu
experiment
infect
mutant
lack
two
three
nlink
site
unlik
monkey
infect
parent
viru
made
antibodi
high
titer
neutral
activ
mutant
virus
sera
mutantinfect
anim
show
reactiv
peptid
correspond
mutat
sequenc
unlik
monkey
infect
wildtyp
viru
howev
whether
antibodi
recogn
underli
peptid
sequenc
actual
capabl
neutral
mutant
viru
rigor
demonstr
use
newli
isol
monoclon
antibodi
mab
rhesu
monkey
origin
show
unambigu
antibodi
specif
peptid
sequenc
underli
carbohydr
effect
neutral
siv
glycan
absent
sinc
none
three
monoclon
antibodi
neutral
parent
viru
presenc
glycan
effici
shield
viru
antibodi
would
otherwis
neutral
viral
infect
anim
sampl
order
success
obtain
cell
line
secret
monoclon
antibodi
peptid
sequenc
underli
carbohydr
site
select
anim
rhesu
macaqu
macaca
mulatta
infect
ie
lack
second
third
glycosyl
site
previou
studi
group
anim
show
high
neutral
titer
plasma
carbohydr
mutant
viru
well
viru
lack
three
glycosyl
site
sampl
use
report
monkey
other
obtain
indianorigin
rhesu
macaqu
hous
new
england
primat
research
center
biosafeti
level
anim
contain
facil
accord
standard
associ
assess
accredit
laboratori
anim
care
harvard
medic
school
anim
care
use
committe
research
conduct
accord
principl
describ
guid
care
use
laboratori
anim
approv
harvard
medic
school
anim
care
use
committe
gener
monoclon
antibodi
sequenc
underli
carbohydr
site
three
differ
mab
specif
sequenc
underli
carbohydr
site
isol
present
studi
start
materi
use
freshli
drawn
blood
rhesu
macaqu
peripher
blood
mononuclear
cell
pbmc
isol
standard
ficol
densiti
gradient
accuspin
sigmaaldrich
saint
loui
mo
immunoglobulin
g
igg
express
cell
subsequ
sort
antiigg
magnet
bead
miltenyi
biotec
inc
auburn
ca
accord
manufactur
instruct
igg
cell
fraction
spinocul
rel
centrifug
forc
rcf
h
room
temperatur
supernat
contain
rhesu
epsteinbarr
viru
ebv
like
herpesviru
presenc
typeb
stimulatori
oligonucleotid
agonist
cpg
invivogen
san
diego
ca
cultur
irradi
feeder
cell
plate
rpmi
medium
supplement
fetal
bovin
serum
fb
mm
lglutamin
mm
hepe
mm
nonessenti
amino
acid
mm
sodium
pyruv
invitrogen
carlsbad
ca
gml
primocin
invivogen
san
diego
ca
hybridomaenhanc
supplement
sigmaaldrich
humid
atmospher
co
feeder
cell
nih
cell
stabli
transfect
human
cell
use
cell
line
kindli
provid
gordon
freeman
use
feeder
cell
thu
provid
effici
costimul
b
cell
togeth
cpg
synthet
oligonucleotid
mimic
bacteri
dna
stimul
b
cell
via
tolllik
receptor
infect
immort
b
cell
could
optim
ensur
feeder
cell
would
stop
divid
still
provid
costimul
secret
growth
factor
cell
gamma
irradi
day
spinocul
cellsml
min
total
dose
gy
seed
plate
humid
atmospher
co
mixtur
feeder
rhesu
cell
incub
describ
replac
onehalf
medium
per
week
supplement
rpmi
without
hybridoma
enhanc
approxim
week
bcell
transform
occur
supernat
screen
standard
enzymelink
immunosorb
assay
elisa
reactiv
synthet
peptid
correspond
mutat
sequenc
underli
glycosyl
site
three
bcell
line
posit
elisa
read
isol
classic
sequentialdilut
clone
fresh
irradi
feeder
cell
monoclon
popul
interest
ensur
monoclon
cell
line
expand
transfer
serumfre
medium
invitrogen
afterward
antibodycontain
medium
harvest
preclear
centrifug
filter
membran
igg
affin
purifi
protein
sepharos
fast
flow
ge
healthcar
piscataway
nj
follow
protein
quantif
nanodrop
uv
spectromet
thermo
fisher
scientif
inc
rockford
il
antibodi
puriti
confirm
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
subsequ
coomassi
blue
stain
data
shown
specif
three
antibodi
confirm
purif
character
follow
monoclon
bcell
line
secret
antibodi
made
avail
nih
aid
research
refer
reagent
program
antibodi
character
antibodi
isol
abil
react
peptid
wqewerkvd
fleeqitalleeaq
correspond
mutat
sequenc
underli
glycosyl
wildtyp
fig
confirm
reactiv
antibodi
test
elisa
gml
recombin
protein
includ
extracellular
portion
obtain
immun
technolog
new
york
ny
use
gml
coat
elisa
plate
variabl
region
heavi
light
chain
mab
sequenc
dna
level
syd
lab
malden
nucleotid
sequenc
analyz
imgtvquest
intern
immunogenet
inform
systemvqueri
standard
http
wwwimgtorg
integr
softwar
analyz
rearrang
immunoglobulin
nucleotid
sequenc
tool
v
j
variabl
divers
join
gene
allel
identifi
align
human
immunoglobulin
germ
line
gene
allel
sequenc
imgt
refer
directori
complementaritydetermin
region
cdr
framework
region
identifi
basi
imgt
uniqu
number
somat
mutat
identifi
twodimension
graphic
represent
variabl
region
creat
also
use
imgtvquest
imgt
collier
de
perl
threedimension
structur
variabl
domain
obtain
rosettaantibodi
antibodymodel
server
pepscan
map
character
epitop
three
monoclon
antibodi
test
reactiv
elisa
overlap
peptid
pepscan
fifteenmerlength
peptid
repres
entir
envelop
env
success
peptid
overlap
amino
acid
aa
obtain
nih
aid
research
refer
reagent
program
mutant
env
peptid
synthes
massachusett
gener
hospit
peptid
core
facil
charlestown
singl
well
halfarea
highbind
polystyren
micropl
corn
costar
lowel
coat
l
peptid
gml
phosphatebuff
salin
pb
overnight
well
block
l
nonfat
powder
milk
pb
h
fifti
microlit
correspond
monoclon
antibodi
dilut
gml
nonfat
powder
milk
pb
ad
well
incub
h
well
wash
five
time
pb
tween
pbstween
l
horseradish
peroxidas
hrp
conjug
goat
antihuman
igg
antibodi
santa
cruz
biotechnolog
santa
cruz
ca
dilut
nonfat
powder
milk
pb
ad
well
incub
h
plate
wash
time
pbstween
develop
l
solubl
tetramethylbenzidin
reagent
calbiochem
gibbstown
nj
reaction
stop
addit
l
acid
stop
solut
southernbiotech
birmingham
al
optic
densiti
nm
measur
use
wallac
victor
plate
reader
perkinelm
waltham
western
blot
analysi
wildtyp
prepar
transient
transfect
cell
pellet
centrifug
rcf
h
pellet
wash
twice
cold
pb
final
concentr
capsid
determin
antigen
captur
assay
advanc
bioscienc
laboratori
inc
kensington
md
equal
volum
laemmli
load
buffer
ad
viru
sampl
incub
min
separ
sdspage
ident
amount
virus
load
per
lane
ng
next
protein
gel
transfer
polyvinyliden
difluorid
pvdf
membran
biorad
laboratori
hercul
ca
membran
block
nonfat
powder
milk
pb
block
solut
h
room
temperatur
incub
indic
antibodi
gml
block
solut
overnight
antibodi
rhesu
monoclon
antibodi
bind
highli
immunogen
region
cytoplasm
domain
area
indic
hir
fig
use
concentr
posit
control
membran
incub
goat
antihuman
igg
hrpconjug
secondari
antibodi
santa
cruz
biotechnolog
dilut
block
solut
h
room
temperatur
specif
signal
detect
enhancedchemiluminesc
system
use
supersign
west
femto
maximum
sensit
chemiluminesc
substrat
thermo
fisher
scientif
similar
condit
use
analyz
recombin
protein
use
ng
per
lane
follow
chang
sampl
incub
min
blot
develop
use
supersign
west
pico
chemiluminesc
substrat
thermo
fisher
scientif
pool
serum
sivinfect
macaqu
use
dilut
block
buffer
posit
control
neutral
assay
neutral
activ
mab
variou
strain
sivmac
measur
use
immort
human
tcell
line
sivseap
sivseap
cell
harbor
tatinduc
secret
engin
alkalin
phosphatas
seap
report
construct
enabl
quantif
siv
infect
measur
seap
product
cultur
supernat
viru
amount
equival
ng
capsid
protein
ng
three
close
space
nlinkedglycosyl
consensu
site
found
depict
area
surround
glycosyl
site
shadow
gray
overlap
peptid
match
sequenc
parent
viru
peptid
repres
amino
acid
sequenc
mutant
viru
asparagin
residu
first
second
third
canon
nxst
consensu
sequenc
carbohydr
attach
chang
structur
similar
glutamin
nxst
qxst
longer
peptid
use
subsequ
screen
antibodi
design
b
repres
pepscan
elisa
overlap
peptid
span
whole
envelop
sequenc
serum
rhesu
monkey
experiment
infect
glycandefici
mutant
lack
sequenc
underli
nlink
carbohydr
site
shadow
gray
region
interest
indic
follow
variabl
region
label
respect
cleavag
site
begin
repres
arrow
bracket
indic
locat
glycosyl
tm
transmembran
domain
hir
stand
highli
immunogen
region
elisa
reactiv
measur
absorb
nm
c
serum
anim
test
peptid
correspond
mutat
viral
sequenc
cover
area
nlink
glycosyl
monkey
select
bcell
sourc
isol
monoclon
antibodi
specif
repres
result
three
independ
experi
shown
chosen
lowest
level
viral
input
would
suffici
give
clear
seap
signal
within
linear
rang
seap
activ
measur
level
suffici
background
give
reliabl
measur
least
irrelev
purifi
rhesu
igg
use
neg
control
serum
sampl
anim
use
posit
control
neutral
assay
perform
plate
set
follow
outer
well
fill
pb
maintain
hydrat
l
medium
rpmi
fb
ad
first
two
inner
column
aliquot
success
dilut
medium
test
antibodi
serum
ad
column
sera
previous
heat
inactiv
min
viru
total
volum
l
indic
concentr
ad
well
column
virusfre
medium
ad
column
mock
plate
incub
h
subsequ
l
sivseap
ad
well
cellsml
final
volum
lwell
plate
incub
humid
atmospher
co
indic
time
day
seap
activ
measur
use
chemiluminesc
phosphalight
seap
assay
system
appli
biosystem
carlsbad
ca
accord
manufactur
recommend
minor
modif
describ
previous
plate
reader
victor
v
multilabel
counter
perkinelm
neutral
report
percentag
seap
activ
cell
cultur
viru
stock
prepar
sivseap
cell
maintain
previous
describ
virus
prepar
transient
transfect
cell
plasmid
bear
fulllength
provir
genom
cell
seed
cell
per
flask
day
transfect
flask
transfect
g
dna
use
calcium
phosphat
method
promega
madison
wi
accord
manufactur
instruct
cultur
medium
replac
fresh
medium
day
transfect
supernat
harvest
day
quantifi
viru
concentr
capsid
supernat
determin
antigen
captur
assay
advanc
bioscienc
laboratori
isol
monoclon
antibodi
peptid
underli
carbohydr
rhesu
monkey
infect
glycandefici
viru
three
glycosyl
attach
site
name
fig
order
test
whether
antibodi
direct
peptid
underli
glycosyl
respons
neutral
glycandefici
mutant
aim
isol
monoclon
antibodi
specif
purpos
chose
one
rhesu
macaqu
anim
previous
infect
glycandefici
mutant
lack
site
confirm
presenc
antibodi
interest
serum
obtain
month
infect
test
pepscan
panel
peptid
overlap
entir
envelop
protein
shown
antibodi
serum
anim
react
appreci
wildtyp
peptid
sequenc
correspond
region
cover
glycosyl
site
fig
peptid
shadow
gray
label
convers
strong
reactiv
shown
establish
immunodomin
region
env
ie
variabl
loop
c
terminu
peptid
ectodomain
highli
immunogen
region
hir
begin
cytoplasm
tail
serum
test
anoth
set
overlap
peptid
mutat
glycosyl
consensu
site
strong
reactiv
peptid
observ
fig
repres
region
beneath
anim
three
monoclon
bcell
line
secret
antibodi
specif
region
gener
ebv
immort
describ
materi
method
specif
marker
longer
oligopeptid
use
correspond
region
aa
start
immedi
c
termin
includ
fig
rhesu
monoclon
antibodi
direct
peptid
underli
carbohydr
show
differ
reactiv
pattern
isotyp
reveal
kappa
light
chain
specif
antibodi
glycosyl
region
verifi
elisa
three
antibodi
bound
effici
longer
peptid
use
screen
peptid
cover
sequenc
bind
recombin
protein
lack
thu
demonstr
specif
fig
three
mab
bound
recombin
extracellular
portion
serum
monkey
use
posit
control
fine
map
epitop
test
elisa
overlap
peptid
thu
span
glycosyl
region
either
mutant
wildtyp
version
sequenc
detail
fig
antibodi
show
strong
bind
peptid
moder
bind
peptid
fig
black
bar
significantli
react
wildtyp
peptid
antibodi
bound
strongli
mutant
peptid
robustli
crossreact
wildtyp
fig
gray
bar
antibodi
bound
poorli
slightli
background
like
detect
bind
wildtyp
peptid
fig
white
bar
serum
use
parallel
comparison
fig
crosshatch
bar
reactiv
three
monoclon
antibodi
wildtyp
may
seem
surpris
given
rel
inabl
two
react
appreci
peptid
correspond
wildtyp
sequenc
howev
note
ng
use
elisa
well
data
fig
measur
rel
effici
bind
show
next
section
fig
western
blot
effici
bind
much
weaker
wildtyp
sequenc
mutat
sequenc
western
blot
show
effici
bind
glycosylationdefici
ineffici
bind
wildtyp
obtain
viral
particl
test
whether
monoclon
antibodi
abl
react
western
blot
infecti
viral
particl
wildtyp
glycandefici
pellet
normal
amount
use
western
blot
analysi
doubl
mutant
pick
assay
lack
glycosyl
site
locat
vicin
sequenc
recogn
three
antibodi
effici
bound
glycandefici
version
wherea
reactiv
wildtyp
version
protein
undetect
fig
consist
elisa
result
gave
stronger
signal
close
follow
show
weakest
signal
previous
isol
rhesu
monoclon
antibodi
whose
epitop
locat
cytoplasm
domain
protein
therefor
influenc
extracellular
glycosyl
use
posit
control
demonstr
equival
level
protein
per
lane
inde
imag
analysi
demonstr
equival
level
wildtyp
mutant
per
ng
virion
fig
imag
label
western
blot
run
parallel
equal
exposur
time
chosen
allow
direct
comparison
although
low
amount
protein
present
virion
prepar
result
detect
wildtyp
monoclon
antibodi
reactiv
western
blot
detect
much
larger
amount
recombin
commerciallyavail
wildtyp
protein
use
fig
consist
elisa
data
fig
show
strongest
reactiv
follow
pool
sera
sivinfect
anim
use
posit
control
sequenc
show
similar
variabl
region
differ
character
nucleotid
sequenc
obtain
monoclon
antibodi
revers
transcript
rt
pcr
cdna
amplif
sequenc
confirm
monoclon
cell
line
one
sequenc
found
antibodi
fig
inform
rhesu
macaqu
incomplet
analyz
variabledomain
sequenc
heavi
light
chain
base
human
sequenc
nomenclatur
highli
homolog
rhesu
macaqu
analysi
imgtvquest
confirm
three
deriv
product
rearrang
sequenc
stop
codon
proper
infram
junction
softwar
also
use
identifi
cdr
heavi
chain
kappa
light
chain
togeth
respect
framework
region
align
three
amino
acid
sequenc
heavi
light
chain
reveal
quit
differ
among
three
mono
materi
method
rhesu
macaqu
infect
lack
screen
base
elisa
reactiv
peptid
correspond
mutat
glycandefici
sequenc
underli
nlink
carbohydr
site
fig
elisa
reactiv
measur
absorb
nm
three
antibodi
test
elisa
reactiv
peptid
recombin
protein
serum
anim
antibodyproduc
bcell
line
origin
use
posit
control
bottom
b
order
character
bind
reactiv
overlap
peptid
span
either
mutant
left
half
peptid
wildtyp
right
half
peptid
glycosyl
region
assay
repres
result
three
independ
experi
shown
clonal
antibodi
fig
convers
region
similar
one
anoth
region
ident
spars
amino
acid
differ
characterist
reveal
along
framework
region
antibodi
fig
also
gener
twodimension
structur
represent
variabl
domain
use
imgt
collier
de
perl
fig
represent
clearli
identifi
cdr
color
code
fig
five
characterist
conserv
posit
variabl
domain
confirm
cy
first
cy
trp
hydrophob
case
leu
heavi
light
chain
cy
second
cy
jtrp
jphe
heavi
light
chain
respect
end
junction
comparison
cdr
sequenc
analyz
separ
tabl
length
amino
acid
heavi
chain
cdr
similar
aa
aa
aa
equal
light
chain
cdr
common
length
aa
respect
addit
analysi
variabl
domain
imgtvquest
reveal
three
threenucleotid
insert
aa
correspond
first
gli
ly
underlin
tabl
comparison
publish
human
sequenc
use
imgt
vquest
identifi
equival
closest
germ
line
gene
antibodi
like
origin
shown
tabl
variabl
segment
v
select
heavi
chain
vdj
recombin
correspond
gene
allel
three
monoclon
antibodi
furthermor
also
share
divers
join
j
segment
read
frame
respect
deriv
read
frame
correspondingli
closest
germ
line
gene
v
j
segment
kappa
light
chain
three
monoclon
antibodi
respect
note
light
chain
segment
structur
predict
variabl
domain
reveal
common
configur
dispar
disposit
order
obtain
predict
threedimension
structur
variabl
domain
amino
acid
sequenc
submit
antibodymodel
server
rosettaantibodi
tool
built
rosetta
structur
predict
suit
compris
knowledgebas
techniqu
templat
select
graft
cdr
loop
de
novo
loop
model
creat
dock
optim
rel
orient
light
heavi
chain
fullprotocol
approach
chosen
achiev
refin
variabl
heavi
light
chain
structur
togeth
effici
model
predict
model
variabl
domain
shown
antibodi
fig
top
predict
structur
compar
three
antibodi
consist
similar
found
primari
sequenc
fact
virtual
share
light
chain
howev
closer
look
reveal
three
fairli
differ
loop
structur
begin
angl
toward
light
chain
turn
opposit
direct
despit
similar
structur
featur
loop
get
close
light
chain
angl
torsion
appear
pronounc
show
diverg
structur
two
one
two
pronounc
turn
confer
thin
invert
u
shape
evalu
differ
like
cdr
conform
also
render
fig
bottom
model
wider
rang
lowenergi
posit
therefor
like
conform
gener
maintain
shape
everi
combin
slightli
differ
angl
capac
neutral
glycandefici
mutant
next
test
abil
neutral
wildtyp
correspond
carbohydratedefici
mutant
three
monoclon
antibodi
capabl
neutral
variou
degre
fig
mutant
lack
three
nlink
glycosyl
site
tripleglycandefici
viru
sensit
monoclon
antibodymedi
neutral
three
monoclon
antibodi
exhibit
weak
neutral
activ
mutant
neutral
detect
wildtyp
close
relat
highli
neutralizationsensit
strain
differ
env
sequenc
eight
amino
acid
posit
none
vicin
glycosyl
region
expect
strain
differ
sequenc
region
target
epitop
also
neutral
fig
everi
viru
neg
control
irrelev
rhesu
igg
run
parallel
concentr
antibodi
serum
use
posit
control
siv
neutral
antibodi
use
degre
neutral
vari
consider
one
antibodi
anoth
potent
antibodi
follow
dose
requir
neutral
ic
calcul
shown
tabl
lentivirus
possess
envelop
protein
dens
glycosyl
nlink
glycosyl
surfac
subunit
siv
demonstr
restrict
abil
antibodi
access
restrict
abil
neutral
infect
much
less
known
role
nlink
glycosyl
transmembran
subunit
three
site
nlink
glycosyl
extracellular
domain
base
earlier
work
yust
et
al
isol
three
monoclon
antibodi
rhesu
macaqu
origin
name
recogn
sequenc
correspond
carbohydr
attach
site
bind
amino
acid
sequenc
wqewerkvdfleeqitalleeaq
effect
neutral
glycandefici
mutant
thu
establish
abil
antibodi
direct
stretch
neutral
infect
carbohydr
attach
carbohydr
sever
limit
abil
host
mount
antibodi
respons
underli
peptid
sequenc
antibodi
present
abl
neutral
infect
viru
lack
carbohydr
region
site
seem
key
player
protect
effect
three
mab
three
site
appar
contribut
sinc
tripl
mutant
consist
sensit
neutral
three
antibodi
interestingli
three
monoclon
antibodi
exhibit
level
reactiv
deriv
wildtyp
sequenc
elisa
fig
western
blot
fig
need
note
howev
rel
larg
amount
purifi
use
assay
fig
furthermor
reactiv
surpris
given
reactiv
peptid
correspond
wildtyp
sequenc
fig
monoclon
antibodi
certainli
react
consider
strongli
mutant
sequenc
wildtyp
sequenc
western
blot
fig
peptid
elisa
fig
analys
variabledomain
sequenc
heavi
light
chain
base
human
sequenc
nomenclatur
highli
homolog
rhesu
macaqu
three
antibodi
share
highli
similar
light
chain
heavychain
variabl
segment
v
appear
deriv
germ
line
allel
divers
join
j
segment
heavi
chain
least
seem
origin
germ
line
allel
three
antibodi
show
characterist
amino
acid
chang
along
variabl
domain
possibl
particular
v
j
segment
select
matur
b
cell
may
especi
effect
combin
target
glycosyl
region
similitud
suggest
three
antibodi
like
origin
common
b
cell
despit
similar
genet
level
differ
sever
characterist
particular
peptid
bind
profil
importantli
diverg
heavili
sequenc
indic
consider
hypermut
dissimilar
amino
acid
sequenc
might
account
specif
properti
antibodi
differ
like
key
determin
epitop
specif
affin
consist
notion
demonstr
cdr
light
chain
assum
canon
conform
sole
wide
rang
variat
length
shape
agreement
structur
model
variabl
domain
shown
variabl
conform
regard
gli
found
could
respons
similar
turn
found
four
gli
found
could
account
thin
invert
u
shape
three
antibodi
glycin
posit
glycin
aros
insert
somat
mutat
thu
glycin
may
also
well
import
recognit
nonglycosyl
sequenc
result
describ
yust
et
al
public
demonstr
appear
antibodi
underli
peptid
monkey
infect
viru
monkey
infect
parent
wildtyp
viru
public
appear
antibodi
hightit
neutral
activ
mutant
viru
anim
infect
mutant
viru
also
unambigu
demonstr
howev
whether
antibodi
direct
underli
peptid
respons
neutral
activ
directli
demonstr
show
antibodi
direct
underli
peptid
neutral
activ
specif
mutant
virus
data
establish
conclus
presenc
glycan
effect
shield
viru
antibodi
would
otherwis
neutral
viral
infect
monoclon
antibodi
use
posit
control
neutral
ic
gml
color
code
rel
neutral
potenc
red
high
orang
medium
yellow
low
gray
nondetect
neutral
maximum
dose
antibodi
neutral
glycandefici
mutant
abil
red
yellow
orang
neutral
five
differ
glycandefici
mutant
lack
one
two
three
glycosyl
site
parent
control
viru
stock
virion
obtain
transient
transfect
cell
normal
amount
use
infect
sivseap
cell
seri
dilut
antibodi
seap
activ
measur
day
infect
neutral
curv
shown
percentag
seap
activ
versu
activ
cell
infect
viru
absenc
antibodi
fit
logarithm
scale
percentag
normal
irrelev
rhesu
igg
concentr
use
neg
control
pink
serum
glycandefici
sivinfect
anim
use
posit
control
siv
infect
antibodi
infect
blue
antibodi
concentr
serum
dilut
fold
indic
two
separ
abscissa
dot
line
indic
upper
line
lower
line
maxim
viral
replic
neg
neg
control
po
posit
control
repres
result
three
independ
experi
shown
